DOCSLIB.ORG

Cow's Milk Protein Allergy As a Model of Food Allergies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cow's Milk Protein Allergy As a Model of Food Allergies nutrients Review Cow’s Milk Protein Allergy as a Model of Food Allergies Arianna Giannetti 1 , Gaia Toschi Vespasiani 2 , Giampaolo Ricci 3, Angela Miniaci 1, Emanuela di Palmo 1 and Andrea Pession 1,* 1 Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy; [email protected] (A.G.); [email protected] (A.M.); [email protected] (E.d.P.) 2 Specialty School of Paediatrics, Alma Mater Studiorum, University of Bologna, via G.Massarenti n 11, 40138 Bologna, Italy; [email protected] 3 Department of Medical and Surgical Sciences (DIMEC), University of Bologna, via G. Massarenti n.9, 40138 Bologna, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-051-214-4443; Fax: +39-051-346044 Abstract: Cow’s milk allergy (CMA) is one of the most common food allergies in infants, and its prevalence has increased over recent years. In the present paper, we focus on CMA as a model of food allergies in children. Understanding the diagnostic features of CMA is essential in order to manage patients with this disorder, guide the use of an elimination diet, and find the best moment to start an oral food challenge (OFC) and liberalize the diet. To date, no shared tolerance markers for the diagnosis of food allergy have been identified, and OFC remains the gold standard. Recently, oral immunotherapy (OIT) has emerged as a new therapeutic strategy and has changed the natural history of CMA. Before this, patients had to strictly avoid the food allergen, resulting in a decline in quality of life and subsequent nutritional, social, and psychological impairments. Thanks to the introduction of OIT, the passive approach involving rigid exclusion has changed to a proactive one. Citation: Giannetti, A.; Toschi Both the heterogeneity in the diagnostic process among the studies and the variability of OIT data Vespasiani, G.; Ricci, G.; Miniaci, A.; limit the comprehension of the real epidemiology of CMA, and, consequentially, its natural history. di Palmo, E.; Pession, A. Cow’s Milk Therefore, well-planned randomized controlled trials are needed to standardize CMA diagnosis, Protein Allergy as a Model of Food prevention, and treatment strategies. Allergies. Nutrients 2021, 13, 1525. https://doi.org/10.3390/nu13051525 Keywords: cow’s milk allergy; oral food challenge; oral immunotherapy; diet; skin prick test; serum-specific IgE; breastfeeding Academic Editors: Elvira Verduci, Gian Vincenzo Zuccotti and Diego Peroni Received: 30 March 2021 1. Introduction Accepted: 26 April 2021 The prevalence of food allergies (FAs) and especially cow’s milk allergy (CMA, cur- Published: 30 April 2021 rently one of the most common FAs among children [1,2]) has increased in recent decades. CMA is defined as a reproducible adverse reaction to one or more cow’s milk (CM) Publisher’s Note: MDPI stays neutral protein (usually casein or serum β-lactoglobulin) [3]. The underlying immunological with regard to jurisdictional claims in mechanism, presentation times, and organs involved differentiate CMA from other adverse published maps and institutional affil- reactions to CM such as lactose intolerance [4]. iations. CMA, like all FAs, can be divided into two main categories according to the type of immunological mechanism underlying it: immunoglobulin (Ig)E-mediated or non-IgE mediated [5] (Figure1). IgE-mediated reactions are the most common. On the other hand, there are non-IgE mediated reactions that can arise from other cellular processes involving Copyright: © 2021 by the authors. eosinophils or T-cells. Licensee MDPI, Basel, Switzerland. CMA usually occurs in the first 2 years of life and especially within the first year, This article is an open access article unlike other allergies, such as peanut, tree nuts, fish and shellfish allergies which may distributed under the terms and develop later in childhood or adulthood. Most allergies (including CM allergies) resolve conditions of the Creative Commons spontaneously during childhood or adolescence, whereas peanut and tree nut allergies are Attribution (CC BY) license (https:// more likely to persist into adulthood [6,7]. creativecommons.org/licenses/by/ 4.0/). Nutrients 2021, 13, 1525. https://doi.org/10.3390/nu13051525 https://www.mdpi.com/journal/nutrients NutrientsNutrients2021 2021, 13, 13, 1525, x FOR PEER REVIEW 22 ofof 21 21 FigureFigure 1. 1.Clinical Clinical presentation presentation of of IgE IgE and and non non IgE IgE CMA. CMA. 2. Cow’sCMA Milk usually Composition occurs in the first 2 years of life and especially within the first year, unlikeCM other contains allergies, from such 30 to as 35 peanut, g of protein tree nuts, per liter fish andand manyshellfish proteins, allergies which which are may all potentialdevelop allergenslater in childhood [8]. or adulthood. Most allergies (including CM allergies) resolve spontaneouslyThrough the during acidification childhood of raw or skimadolescence milk to, pHwhereas 4.6 at peanut 20 ◦C it and is possible tree nut to allergies obtain twoare differentmore likely fractions: to persist the into coagulum, adulthood containing [6,7]. the casein proteins which account for 80% of the fraction, and the lactoserum (whey proteins), representing 20% of the total milk proteins2. Cow’s [9 M].ilk These Composition proteins can also be divided into soluble and insoluble proteins [10]. TheCM major contains milk from allergens 30 to are 35 solubleg of protein proteins, per namedliter and whey many proteins, proteins, which which represent are all approximatelypotential allergens 20% of[8] total. proteins [11]. Allergens present in the serum fraction include α-lactalbuminThrough (Bosthe acidification d 4) and β -lactoglobulinof raw skim milk (Bos to dpH 5), 4.6 which at 20 are°C it the is possible most abundant, to obtain andtwo immunoglobulins different fractions: (Bos the dcoagulum, 7), serum albumincontaining (BSA, the Boscasein d 6), proteins and traces which of lactoferrin,account for lysozyme,80% of the proteose-peptone, fraction, and the lactoserum and transferrin (whey [9 ].proteins), In particular representing lactoferrin, 20% lactoperoxidase, of the total milk andproteins lysozyme [9]. These are important proteins can antimicrobial also be divided agents, in whileto soluble lactoferrin, and insolubleβ-lactoglobulin, proteins [10] and. α-lactalbuminThe major are milk important allergens tumor are soluble suppressors proteins, [12 ].named whey proteins, which represent approximatelyThe remaining 20% 80% of total is represented proteins [11] by. insolubleAllergens proteins present knownin the serum as caseins fraction (known include as Bosα-lactalbumin d 8). Total caseins (Bos d can4) and be divided β-lactoglobu into fourlin (Bos proteins, d 5), representingwhich are the different most abundant, percentages and ofimmunoglobulins the whole fraction: (Bosα S1-casein,d 7), serum which albumin is the (BSA, most Bos important d 6), and (Bos traces d 9,of 32%), lactoferrin, as well lyso- as αzyme,S2-casein proteose (Bos- dpeptone 10, 10%),, andβ-casein transferrin (Bos [9] d.11, In particular 28%), and lactoferrin,κ-casein (Bos lactoperoxidase d 12, 10%). The, and mainlysozyme role of are caseins important relates antimicrobial to their mineral agents, binding while and lactoferrin, carrier capacity, β-lactoglobulin specifically, and for α- calciumlactalbumin andphosphorus are important [12 tumor]. suppressors [12]. CMAsThe remaining are most 80% frequently is represented caused byby wheyinsoluble proteins, proteins but known they can as alsocaseins be promoted (known as byBos caseins d 8,). Total [13]. Ascaseins a matter can be of divided fact, most into patients four proteins, are sensitized representing to casein different (Bos dpercent- 8), β- lactoglobulinages of the whole (Bos fraction: d 5), and ααS1-lactalbumin-casein, which (Bos is dthe 4), most which important are the major(Bos d milk9, 32%), allergens. as well Thereas αS2 are-casein only (Bos a few d 10, studies 10%), thatβ-casein describe (Bos d allergies 11, 28%) to, and minor κ-casein serum (Bos proteins d 12, 10%). such The as immunoglobulin,main role of caseins bovine relates serum to their albumin, mineral or lactoferrin binding and [14 ].carrier capacity, specifically for calciumCM containsand phosphorus at least 20[12] potentially. allergenic proteins [15]. Most children with milk- allergyCMA are sensitizeds are most tofrequently more than caused one allergen, by whey with proteins, a greater but variabilitythey can also of symptoms. be promoted by caseinsTable1 provides[13]. As a shortmatter synthesis of fact, most of cow’s patients milk allergensare sensitized and their to casein characteristics. (Bos d 8), β- Nutrients 2021, 13, 1525 3 of 21 Table 1. Main characteristics of CM allergens, adapted from Hochwallner [8]. Allergen Protein Concentration Prevalence (% Allergenic Activity Name (g/L) Size (kDa) of Patients) (% of Patients) Bos d 4 α–Lactalbumin 1–1.5 14.2 0–67 12 Bos d 5 β–Lactoglobulin 3–4 18.3 13–62 19 Whey (20%) (5 g/L) Bos d 6 Bovine serum albumin 0.1–0.4 66.3 0–76 1 Bos d 7 Immunoglobulins 0.6–1 160 12–36 Lactoferrin 0.09 80 0–35 3 Bos d 9 αS1–casein 12–15 23.6 65–100 26 Whole Bos d 10 αS2–casein 3–4 25.2 casein (80%) (30 g/L) Bos d 11 β–casein 9–11 24 35–44 35 Bos d 12 k–casein 3–4 19 35–41 26 3. Subtypes of Immune-Mediated Reactions to CM CMAs have a range of clinical manifestations, with variable intensity. Moreover, clinical features can differ from “immediate” to “delayed” reactions, and this reflects the different pathogenesis (Figure1). Approximately 60% of CMA are IgE-mediated, although estimates change according to the study population and age [1]. The remaining 40% is divided into non IgE-mediated and mixed forms. The latter have different underlying mechanisms, presentations, and implications, which complicate the attempts to estimate the prevalence of CMA. Non IgE-mediated CMAs are caused by less clear immune mechanisms.
Load more

Recommended publications
  • Food Allergy Outline
    Allergy Evaluation-What it all Means & Role of Allergist Sai R. Nimmagadda, M.D.. Associated Allergists and Asthma Specialists Ltd. Clinical Assistant Professor Of Pediatrics Northwestern University Chicago, Illinois Objectives of Presentation • Discuss the different options for allergy evaluation. – Skin tests – Immunocap Testing • Understand the results of Allergy testing in various allergic diseases. • Briefly Understand what an Allergist Does Common Allergic Diseases Seen in the Primary Care Office • Atopic Dermatitis/Eczema • Food Allergy • Allergic Rhinitis • Allergic Asthma • Allergic GI Diseases Factors that Influence Allergies Development and Expression Host Factors Environmental Factors . Genetic Indoor allergens - Atopy Outdoor allergens - Airway hyper Occupational sensitizers responsiveness Tobacco smoke . Gender Air Pollution . Obesity Respiratory Infections Diet © Global Initiative for Asthma Why Perform Allergy Testing? – Confirm Allergens and answer specific questions. • Am I allergic to my dog? • Do I have a milk allergy? • Have I outgrown my allergy? • Do I need medications? • Am I penicillin allergic? • Do I have a bee sting allergy Tests Performed in the Diagnostic Allergy Laboratory • Allergen-specific IgE (over 200 allergen extracts) – Pollen (weeds, grasses, trees), – Epidermal, dust mites, molds, – Foods, – Venoms, – Drugs, – Occupational allergens (e.g., natural rubber latex) • Total Serum IgE (anti-IgE; ABPA) • Multi-allergen screen for IgE antibody Diagnostic Allergy Testing Serological Confirmation of Sensitization History of RAST Testing • RAST (radioallergosorbent test) invented and marketed in 1974 • The suspected allergen is bound to an insoluble material and the patient's serum is added • If the serum contains antibodies to the allergen, those antibodies will bind to the allergen • Radiolabeled anti-human IgE antibody is added where it binds to those IgE antibodies already bound to the insoluble material • The unbound anti-human IgE antibodies are washed away.
    [Show full text]
  • TITLE of STUDY Milk Allergy Is a Very Common Problem in Children. Milk
    TITLE OF STUDY Milk Desensitization and Induction of Tolerance in Children Milk Allergy is a very common problem in children. Milk-induced symptoms effect up-to 20% of children, with detrimental effects on nutrition during critical periods of growth. Moreover, approximately 2-5% of children make IgE antibodies against cow’s milk, which are responsible for severe allergic reactions and anaphylaxis. Milk is the second most common food causing life-threatening anaphylaxis in North America and Europe, and the most common food to cause life- threatening symptoms world-wide. Due to the ubiquitous nature of dairy products in our diet, milk is extremely difficult to avoid. Treatment of milk allergy is currently based on strict avoidance, and patients must carry injectable adrenalin (e.g. Epipen). Our study will assess a novel and potentially life-changing therapy, by actively treating milk allergy with Oral Immunotherapy. This may allow patients to safely consume dairy products. Treatment with oral-immunotherapy has been piloted in the USA and Europe, but there is no current research into milk- immunotherapy in Canada, depriving our population of a potential cure for this very common problem. We propose to perform a well-defined clinical study, using proper control groups and immunological measures to properly understand the ideal patients and the safest and most efficacious methodologies. If successful, this study will clearly increase the margin of safety for children and young adults who suffer from life-threatening milk allergy. It can also increase the consumption of dairy products within this population, providing nutritional benefits including improved bone mineralization and growth.
    [Show full text]
  • Peptide Allergen Immunotherapy: a New Perspective in Olive-Pollen Allergy
    pharmaceutics Review Peptide Allergen Immunotherapy: A New Perspective in Olive-Pollen Allergy David Calzada 1,†, Lucía Cremades-Jimeno 1,†, María López-Ramos 1 and Blanca Cárdaba 1,2,* 1 Immunology Department, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain; [email protected] (D.C.); [email protected] (L.C.-J.); [email protected] (M.L.-R.) 2 Ciber de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Allergic diseases are highly prevalent disorders, mainly in industrialized countries where they constitute a high global health problem. Allergy is defined as an immune response “shifted toward a type 2 inflammation” induced by the interaction between the antigen (allergen) and IgE antibodies bound to mast cells and basophils that induce the release of inflammatory mediators that cause the clinical symptoms. Currently, allergen-specific immunotherapy (AIT) is the only treatment able to change the course of these diseases, modifying the type 2 inflammatory response by an allergenic tolerance, where the implication of T regulatory (Treg) cells is considered essential. The pollen of the olive tree is one of the most prevalent causes of respiratory allergic diseases in Mediterranean countries, inducing mainly nasal and conjunctival symptoms, although, in areas with a high antigenic load, olive-tree pollen may cause asthma exacerbation. Classically, olive-pollen allergy treatment has been based on specific immunotherapy using whole-olive pollen extracts. Citation: Calzada, D.; Despite extracts standardization, the effectiveness of this strategy varies widely, therefore there is a Cremades-Jimeno, L.; López-Ramos, need for more effective AIT approaches.
    [Show full text]
  • Allergen Immunotherapy in Asthma; What Is New? Giovanni Passalacqua*, Anthi Rogkakou, Marcello Mincarini and Giorgio Walter Canonica
    Passalacqua et al. Asthma Research and Practice (2015) 1:6 DOI 10.1186/s40733-015-0006-2 REVIEW Open Access Allergen immunotherapy in asthma; what is new? Giovanni Passalacqua*, Anthi Rogkakou, Marcello Mincarini and Giorgio Walter Canonica Abstract The use and role of allergen immunotherapy (AIT) in asthma is still a matter of debate, and no definite recommendation about this is made in guidelines, both for the subcutaneous and sublingual routes. This is essentially due to the fact that most controlled randomised trials were not specifically designed for asthma, and that objective measures of pulmonary function were only occasionally considered. Nonetheless, in many trials, favourable results in asthma (symptoms, medication usage, bronchial reactivity) were consistently reported. There are also several meta analyses in favour of AIT, although their validity is limited by a relevant methodological heterogeneity. In addition to the crude clinical effect, a disease modifying action of AIT (prevention of asthma onset and long-lasting effects) have been reported. The safety is an important aspect to consider in asthma. Fatalities were rare: in Europe no fatality was reported in the last three decades, as in the United States in the last 4 years. Based on previous surveys, and common sense, uncontrolled asthma is still recognized as the most important risk factor for severe adverse events. On the contrary, there is no evidence that AIT can worsen or induce asthma. According to the available evidence, AIT can be safely used as add-on treatment when asthma is associated with rhinitis (a frequent condition), provided that asthma is adequately controlled by pharmacotherapy.
    [Show full text]
  • Allergen Immunotherapy
    Allergen Immunotherapy Introduction This Factsheet is a summary of the various forms of immunotherapy. We focus primarily on food allergies and insect sting allergy (which are the core work of the Anaphylaxis Campaign) but also give some basic information on treatments for allergic rhinitis (hay fever). Some reference is made to treatments for eczema and asthma. Throughout this Factsheet you will see brief medical references given in brackets. Full references are provided at the end. What is allergen immunotherapy? Allergy occurs when a person’s immune system reacts in an inappropriate or exaggerated way to a food or substance that, in the majority of people, causes no symptoms. A food or substance that causes an allergic reaction is called an allergen. Allergen immunotherapy, previously known as desensitisation, is a medical treatment for allergies. The idea is that the patient’s immune system can be ‘trained’ to tolerate the allergen and therefore not cause allergic symptoms. Allergen immunotherapy for hay fever and asthma has been shown to have benefits for many years after stopping the treatment, where treatment has been ongoing for at least 3-5 years. This has not yet been shown for food allergy to date. Research is also underway to assess whether immunotherapy can potentially reduce the risk of the development of asthma and new allergies. There is some evidence that pollen immunotherapy for hay fever reduces the subsequent risk of developing asthma and that therapy to treat one allergy reduces the subsequent risk of developing reactions to other allergens (Des Roches A, 1997; Purello D, 2001; Panjo GB, 2001).
    [Show full text]
  • Rush Article
    Letters / Ann Allergy Asthma Immunol 122 (2019) 331e349 347 negative, including those related to the episode. A positive skin test presented was attributable to other components (enzymes and was defined for a minimum wheal diameter 3 mm larger than the other mediators) present in the seminal fluid,8 responsible for local negative control. symptoms as well as positive results when performing skin and Total and specific immunoglobulin E (IgE) were measured by basophil activation tests; 2) The slightly acidic vaginal pH9 could ImmunoCAP (Thermo Fisher Scientific). Specific IgE was repeatedly influence the biological effect of seminal fluid (the human prostatic negative for seminal fluid extract (0.02-0.08-0.01 kUA/L). Specific kallikrein is a basic protein that may become neutralized by the IgE measurements were positive for: dog dander, 17.8 kUA/L; dog vaginal acid pH). In fact, reports have been made of women prostatic kallikrein (Can f 5), 27.70 kUA/L; Olea europea pollen, 8.57 sensitive to seminal fluid complaining of local symptoms after 10 kUA/L; latex, 7.5 kUA/L; Hev b, 6.01 20.30 kUA; Heb v 6.02 19.50 kUA/ vaginal intercourse ; 3) The anal area is highly irrigated by the L; and negative (<0.35 kUA/L) for dog lipocaline and other latex hemorrhoid plexus, which facilitates local absorption. components. Total IgE was above normal levels (1,330 kU/L). We conclude that in a case of anaphylaxis after sexual inter- Baseline serum tryptase was within normal levels (5.4 mg/L). course, the diagnosis should address the identification of sensitivity Basophil activation test (BASOTEST, Beckton-Dickinson), per- to seminal fluid components.
    [Show full text]
  • Milk Allergy
    Allergic reactions Allergic reactions are severe adverse reactions that occur when the body’s immune system overreacts to a particular allergen.These reactions may be caused by food, insect stings, latex, medications and other substances. In Canada, the nine priority food allergens Milk are peanuts, tree nuts, sesame seeds, milk, eggs, seafood (fish, crustaceans and shellfish), soy, wheat One of the nine most and sulphites (a food additive). common food allergens What are the symptoms of an allergic reaction? When someone comes in contact with an allergen, the symptoms of a reaction may develop quickly and rapidly progress from mild to severe. The most severe form of an allergic reaction is called anaphylaxis. Symptoms can include breathing difficulties, a drop in blood pressure or shock, which may result in loss of consciousness and even death. A person experiencing an allergic reaction may have any of the following symptoms: • Flushed face, hives or a rash, red and itchy skin • Swelling of the eyes, face, lips, throat and tongue • Trouble breathing, speaking or swallowing • Anxiety, distress, faintness, paleness, sense of doom, weakness • Cramps, diarrhea, vomiting • A drop in blood pressure, rapid heart beat, loss of consciousness How are food allergies and severe allergic reactions treated? Currently there is no cure for food allergies. The only option is complete avoidance of the specific allergen. Appropriate emergency treatment for anaphylaxis (a severe food allergy reaction) includes an injection of adrenaline, which is available in an auto-injector device. Adrenaline must be administered as soon as symptoms of a severe allergic reaction appear.The injection must be followed by further treatment and observation in a hospital emergency room.
    [Show full text]
  • Cow's Milk Allergy, Children [N = 120] Limits: Published Between 1St January 1999 and 30Th June 2009, Humans, English, 0-18 Years
    REVIEW ARTICLE World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines Alessandro Fiocchi, (Chair), Jan Brozek, Holger Schu¨nemann, (Chair), Sami L. Bahna, Andrea von Berg, Kirsten Beyer, Martin Bozzola, Julia Bradsher, Enrico Compalati, Motohiro Ebisawa, Maria Antonieta Guzman, Haiqi Li, Ralf G. Heine, Paul Keith, Gideon Lack, Massimo Landi, Alberto Martelli, Fabienne Rancé, Hugh Sampson, Airton Stein, Luigi Terracciano, and Stefan Vieths Keywords: Cow milk allergy; oral food challenge; epidemiology; Haiqi Li, MD, Professor of Pediatric Division, Department of DBPCFC; amino acid formula; hydrolyzed milk formula; Primary Child Care, Children’s Hospital, Chongqing Med- hydrolyzed rice formula; hydrolyzed soy formula; skin prick test; ical University, China, 400014. specific IgE; OIT; SOTI; GRADE Ralf G. Heine, MD, FRACP, Department of Allergy & Immunology, Royal Children’s Hospital, University of Authorship Melbourne, Murdoch Children’s Research Institute, Mel- bourne, Australia. Alessandro Fiocchi, MD, Pediatric Division, Department of Paul Keith, MD, Allergy and Clinical Immunology Division, Child and Maternal Medicine, University of Milan Medical Department of Medicine, McMaster University, Hamilton, School at the Melloni Hospital, Milan 20129, Italy. a Ontario, Canada. Holger Sch¨unemann, MD, Department of Clinical Epidemiology Gideon Lack, MD, King’s College London, Asthma-UK & Biostatistics, McMaster University Health Sciences Centre, Centre in Allergic Mechanisms of Asthma, Department of 1200 Main Street West Hamilton, ON L8N 3Z5, Canada. Pediatric Allergy, St Thomas’ Hospital, London SE1 7EH, Sami L. Bahna, MD, Pediatrics & Medicine, Allergy & United Kingdom. Immunology, Louisiana State University Health Sciences Massimo Landi, MD, National Pediatric Healthcare System, Center, Shreveport, LA 71130. Ј Italian Federation of Pediatric Medicine, Territorial Pediat- Andrea Von Berg, MD, Research Institute, Children s depart- ric Primary Care Group, Turin, Italy.
    [Show full text]
  • Milk Allergen Component Testing Discover the Connection
    Milk Allergen component testing Discover the connection Whole Allergens and Allergen Components help you diagnose allergy, allowing you to prepare a more comprehensive management plan. Milk Allergen Component testing can help determine which proteins your patient is sensitized to. A specific IgE blood test that detects sensitization to cow’s milk is the first step in discovering your patient’s allergy. Milk Allergen Component tests can help you determine the likelihood of reaction to baked goods, such as cookies or cheese pizza, as well as the likelihood of allergy persistence. CHARACTERISTICS OF INDIVIDUAL PROTEINS Cow’s milk α-lactalbumin β-lactoglobulin Casein f 2 Bos d 4 / f 76 Bos d 5 / f 77 Bos d 8 / f 78 • High levels of cow’s • Susceptible to heat • Susceptible to heat • Resistant to heat Knowing which protein your patient is sensitized to milk IgE may predict denaturation2 denaturation2 denaturation3 3,5-9 the likelihood of • HIGHER RISK of • HIGHER RISK of • HIGHER RISK of can help you develop a management plan. sensitivity, but may not reaction to fresh milk1,3 reaction to fresh milk1,3 reaction to all forms be solely predictive of of milk 1,3,5 • LOWER RISK of • LOWER RISK of reactions to baked milk α-lactalbumin β-lactoglobulin Casein reaction to baked reaction to baked • Patient unlikely to 1 Bos d 4 / f 76 Bos d 5 / f 77 Bos d 8 / f 78 or allergy duration milk1,3* milk1,3* “outgrow” milk allergy Management Considerations with high levels of • Patient likely to • Patient likely to specific IgE to casein4 “outgrow” milk allergy4 “outgrow” milk allergy4 + + - • Avoid fresh milk • Likely to tolerate baked milk products + - - • Baked milk oral food challenge with a specialist *In clinical studies, extensively baked muffin, waffle, and cheese pizza were heated to the point of may be appropriate protein denaturation.
    [Show full text]
  • Milk Allergen by the Numbers
    Milk allergen component testing Bos d4 Milk Bos allergen d5 Bos by the d8 numbers Detect sensitizations to the complete milk protein to create personalized management plans for your patients. High levels of milk IgE may predict the likelihood of sensitivity, but may not be solely predictive of TC 2851 reactions to baked milk or α-lactalbumin allergy duration.1 • Susceptible to heat denaturation2 • HIGHER RISK of reaction to fresh milk1,3 • LOWER RISK of reaction Milk allergen to baked milk1,3,a • Patient likely to “outgrow” component testing milk allergy4 Measurement of specific IgE by blood test that provides objective assessment of sensitization to milk is the first step in discovering your patient’s allergy. Milk allergen component tests can help α-lactalbumin β-lactoglobulin Casein Test interpretations and next steps you determine the likelihood of reaction to baked goods, such as cookies or cheese pizza, as well as • Avoid fresh milk the likelihood of allergy persistence. + + - • Likely to tolerate baked milk products • Baked milk oral food challenge (OFC), Knowing which protein your patient is with a specialist may be appropriate sensitized to can help you develop a + - - • Likely to outgrow allergy management plan.3,5-9 - + - • Avoid all forms of milk +/- +/- + • Unlikely to become tolerant of milk over time • Avoid milk and baked milk products (yogurt, cookies, cakes), as well as products processed with milk (chocolate, sausage, potato chips) % of children with milk allergy 75 do not react to baked milk.3 Bos d4 Bos Bos d5 d8 TC 2852 TC 2853 β-lactoglobulin Casein Determine • Susceptible to heat • Resistant to heat which proteins denaturation2 denaturation3 your patient is • HIGHER RISK of reaction • HIGHER RISK of reaction to fresh milk1,3 to all forms of milk1,3,5 sensitized to.
    [Show full text]
  • ASCIA Health Professional Information Paper
    ASCIA Health Professional Information Paper Nutritional Management of Food Allergy September 2013 This health professional information paper complements ASCIA food allergy e-training for dietitians and other health professionals. The primary purpose of this document is to provide an evidence based, ‘quick reference guide’ to assist dietitians in the management of patients with IgE and non-IgE mediated food allergy. ASCIA has received a grant from WA Department of Health to produce this health professional information paper. 1 ASCIA HP Information Paper: Food allergy | ©ASCIA 2013 Contents Page 1. Adverse food reactions - definitions 3 1.1 Overview 3 1.2 Food allergy 1.2.1 IgE mediated food allergy 3 1.2.2 Non-IgE mediated food allergy 4 1.2.3 Mixed IgE and non-IgE mediated food allergy 4 1.3 Food intolerance 4 2. Diagnosis of food allergy 5 3. Nutrition assessment of food allergic individuals 6 3.1 Initial dietary assessment – adults and children 3.2 Initial dietary assessment – infants and children 6 3.3 Assessing growth 6 3.4 Identifying nutrients at risk with exclusion diets 7 4. Comprehensive management of food allergy 8 4.1 Role of dietitian 8 4.2 Breastfeeding and infant formulas 4.3 Complementary foods/introducing solids 10 4.4 Education 11 Appendices A. Diagnosis and emergency treatment of food allergy 13 B. Nutrition assessment – infants and children with food allergy 15 C. Food labels and food allergy 16 D. Non-IgE mediated and mixed IgE/non-IgE mediated conditions associated 17 with food allergy E. Sources of information about food allergy for dietitians and patients 22 F.
    [Show full text]
  • Monoclonal Antibodies in Treating Food Allergy: a New Therapeutic Horizon
    nutrients Review Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon Sara Manti 1 , Giulia Pecora 1,†, Francesca Patanè 1,†, Alessandro Giallongo 1,* , Giuseppe Fabio Parisi 1 , Maria Papale 1, Amelia Licari 2 , Gian Luigi Marseglia 2 and Salvatore Leonardi 1 1 Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Via Santa Sofia 78, 95123 Catania, Italy; [email protected] (S.M.); [email protected] (G.P.); [email protected] (F.P.); [email protected] (G.F.P.); [email protected] (M.P.); [email protected] (S.L.) 2 Pediatric Clinic, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, Italy; [email protected] (A.L.); [email protected] (G.L.M.) * Correspondence: [email protected]; Tel.: +39-095-4794-181 † These authors contributed equally to this work. Abstract: Food allergy (FA) is a pathological immune response, potentially deadly, induced by exposure to an innocuous and specific food allergen. To date, there is no specific treatment for FAs; thus, dietary avoidance and symptomatic medications represent the standard treatment for managing them. Recently, several therapeutic strategies for FAs, such as sublingual and epicutaneous immunotherapy and monoclonal antibodies, have shown long-term safety and benefits in clinical practice. This review summarizes the current evidence on changes in treating FA, focusing on monoclonal antibodies, which have recently provided encouraging data as therapeutic weapons modifying the disease course. Citation: Manti, S.; Pecora, G.; Patanè, F.; Giallongo, A.; Parisi, G.F.; Keywords: monoclonal antibodies; food allergy; biologics; children; adults Papale, M.; Licari, A.; Marseglia, G.L.; Leonardi, S.
    [Show full text]